Capstone Asset Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $2.37M | Buy |
23,378
+18,706
| +400% | +$1.89M | 0.07% | 352 |
|
|
2017
Q1 | $420K | Sell |
4,672
-4,060
| -46% | -$365K | 0.01% | 1029 |
|
|
2016
Q4 | $665K | Sell |
8,732
-860
| -9% | -$65.5K | 0.02% | 758 |
|
|
2016
Q3 | $799K | Sell |
9,592
-250
| -3% | -$20.8K | 0.02% | 679 |
|
|
2016
Q2 | $811K | Buy |
9,842
+1,420
| +17% | +$117K | 0.02% | 664 |
|
|
2016
Q1 | $640K | Buy |
8,422
+470
| +6% | +$35.7K | 0.02% | 769 |
|
|
2015
Q4 | $639K | Buy |
7,952
+710
| +10% | +$57.1K | 0.02% | 769 |
|
|
2015
Q3 | $460K | Buy |
7,242
+950
| +15% | +$60.3K | 0.01% | 972 |
|
|
2015
Q2 | $443K | Buy |
6,292
+260
| +4% | +$18.3K | 0.01% | 1043 |
|
|
2015
Q1 | $478K | Sell |
6,032
-130
| -2% | -$10.3K | 0.01% | 1109 |
|
|
2014
Q4 | $392K | Sell |
6,162
-260
| -4% | -$16.5K | 0.01% | 1207 |
|
|
2014
Q3 | $384K | Buy |
6,422
+100
| +2% | +$5.98K | 0.01% | 1187 |
|
|
2014
Q2 | $338K | Sell |
6,322
-340
| -5% | -$18.2K | 0.01% | 1319 |
|
|
2014
Q1 | $402K | Sell |
6,662
-100
| -1% | -$6.03K | 0.01% | 1228 |
|
|
2013
Q4 | $359K | Sell |
6,762
-4,238
| -39% | -$225K | 0.01% | 1382 |
|
|
2013
Q3 | $509K | Buy |
11,000
+380
| +4% | +$17.6K | 0.01% | 1283 |
|
|
2013
Q2 | $436K | Buy |
+10,620
| New | +$436K | 0.01% | 1304 |
|